pepstatin A

Pepstatin A is a potent, naturally occurring hexapeptide inhibitor of aspartic proteases, originally isolated from various species of *Streptomyces*. It functions by specifically inhibiting enzymes such as pepsin, cathepsin D, and renin. In the context of chronic kidney disease (CKD), pepstatin A has demonstrated the ability to reduce renal fibrosis in experimental models. Its mechanism involves the inhibition of cathepsin D (CtsD), which leads to an impairment in lysosomal recycling of the urokinase plasminogen activator (uPA). This results in an accumulation of active uPA in the extracellular space, triggering a proteolytic cascade that activates plasmin and potentially matrix metalloproteinases (MMPs), thereby enhancing the degradation of the extracellular matrix (ECM). While primarily utilized as a biochemical research tool, its efficacy in reducing collagen accumulation and thickening of the tubular basement membrane suggests potential therapeutic applications for fibrotic diseases.

Other names

pepstatinIsovaleryl-L-valyl-L-valyl-statyl-L-alanyl-statine